rethinkTHC Search
Menu
Study breakdown

Mice Without NAPE-PLD Show Sex-Based Differences in Opioid and Reward Responses

PreclinicalPreliminary evidence
The takeaway

Mice lacking the endocannabinoid enzyme NAPE-PLD showed sex-dependent changes in how they responded to oxycodone and natural rewards like food and social interaction.

Addiction researchers, neuroscientists studying reward systems, and anyone interested in endocannabinoid-opioid interactions and sex differences in addiction biology.

What the researchers found

NAPE-PLD knockout mice displayed sex-dependent dysregulations in opioid (oxycodone) reward responsiveness and natural reward processing, revealing endocannabinoid-opioid interactions that differ between males and females.

Why it matters

The opioid crisis demands better understanding of addiction biology. The endocannabinoid system interacts closely with opioid reward pathways, and sex differences in these interactions could explain why addiction manifests differently in men and women.

The numbers in context

Tested male and female NAPE-PLD knockout mice on oxycodone reward and natural reward responses — specific group sizes in full methods.

How the study worked

Preclinical study using NAPE-PLD knockout mice to examine sex differences in responsiveness to oxycodone and natural rewards (food, social interaction), testing endocannabinoid-opioid system interactions.

What this study cannot tell us

Global gene knockout, mouse behavior may not translate to human addiction. Oxycodone is one of many opioids. Natural reward paradigms are simplified models of human reward processing.

How to read the evidence

Knockout mouse study revealing important biological mechanisms — foundational for understanding endocannabinoid-opioid interactions but not directly clinical.

When this study was published

Recent preclinical work at the intersection of endocannabinoid and opioid research, addressing the important role of sex differences.

The bigger picture

Cannabis and opioid systems are deeply interconnected. Understanding how disrupting endocannabinoid synthesis affects opioid reward could inform strategies for using cannabinoids in opioid addiction treatment, with attention to sex-specific approaches.

Questions still open

  • Could enhancing endocannabinoid tone help reduce opioid reward and dependence? Should cannabinoid-based addiction treatments consider sex-specific dosing strategies?

Common questions

How are the endocannabinoid and opioid systems connected?
These systems share overlapping brain circuits involved in pain, reward, and mood. Anandamide (made by NAPE-PLD) can modulate how the brain responds to opioids, affecting both pain relief and addiction potential.
Why do sex differences matter for addiction?
Men and women develop addiction differently — different rates, triggers, and treatment responses. This study shows that endocannabinoid-opioid interactions are sex-dependent at a biological level, which could inform more personalized treatments.

Read the original research

Mice lacking the endocannabinoid-synthesizing enzyme NAPE-PLD exhibit sex-dependent dysregulations in responsiveness to oxycodone and a natural reward.

Neuropharmacology, 278, 110573

Citation

Woodward, Taylor J; Sizemore, Emily; Balaji, Ananya; Port, Ada; Hainline, John; Kazi, Hasaan; Luquet, Serge; Mackie, Ken; Hohmann, Andrea G. (2025). Mice lacking the endocannabinoid-synthesizing enzyme NAPE-PLD exhibit sex-dependent dysregulations in responsiveness to oxycodone and a natural reward.. Neuropharmacology, 278, 110573. https://doi.org/10.1016/j.neuropharm.2025.110573

Explore the wider topic